inclusion criteria: * have given the signed informed consent form. * confirmed diagnosis of covid-19 infection by pcr with mild symptoms. * patients who attend the primary care respiratory care module in the participating units and who have symptoms suggestive of covid-19, who comply with the current operational definition. * with or without comorbidities such as hypertension, controlled diabetes mellitus, cardiovascular or respiratory diseases. * controlled diabetes will be considered to be that which is evidenced by results of glycosylated hemoglobin less than 7% in the last 3 tables, whether it is reported in your beneficiary file or by external laboratory results. * electrocardiogram (ecg) normal or with variations without clinical relevance, with qt interval \<450 ms. * no contraindication to study drugs (history of hypersensitivity to study drugs, including macrolides, patients with renal failure (egfr \<40 ml / min) or on renal replacement therapy, patients with a history of retinopathy or macular degeneration.

inclusion criteria: * have given the signed informed consent form. * confirmed diagnosis of covid-19 infection by pcr with mild symptoms. * patients who attend the primary care respiratory care module in the participating units and who have symptoms suggestive of covid-19, who comply with the current operational definition. * with or without comorbidities such as hypertension, controlled diabetes mellitus, cardiovascular or respiratory diseases. * controlled diabetes will be considered to be that which is evidenced by results of glycosylated hemoglobin less than 7% in the last 3 tables, whether it is reported in your beneficiary file or by external laboratory results. * electrocardiogram (ecg) normal or with variations without clinical relevance, with qt interval \<450 ms. * no contraindication to study drugs (history of hypersensitivity to study drugs, including macrolides, patients with renal failure (egfr \<40 ml / min) or on renal replacement therapy, patients with a history of retinopathy or macular degeneration.

inclusion criteria: - have given the signed informed consent form. - confirmed diagnosis of covid-19 infection by pcr with mild symptoms. - patients who attend the primary care respiratory care module in the participating units and who have symptoms suggestive of covid-19, who comply with the current operational definition. - with or without comorbidities such as hypertension, controlled diabetes mellitus, cardiovascular or respiratory diseases. - controlled diabetes will be considered to be that which is evidenced by results of glycosylated hemoglobin less than 7% in the last 3 tables, whether it is reported in your beneficiary file or by external laboratory results. - electrocardiogram (ecg) normal or with variations without clinical relevance, with qt interval <450 ms. - no contraindication to study drugs (history of hypersensitivity to study drugs, including macrolides, patients with renal failure (egfr <40 ml / min) or on renal replacement therapy, patients with a history of retinopathy or macular degeneration.

inclusion criteria: - have given the signed informed consent form. - confirmed diagnosis of covid-19 infection by pcr with mild symptoms. - patients who attend the primary care respiratory care module in the participating units and who have symptoms suggestive of covid-19, who comply with the current operational definition. - with or without comorbidities such as hypertension, controlled diabetes mellitus, cardiovascular or respiratory diseases. - controlled diabetes will be considered to be that which is evidenced by results of glycosylated hemoglobin less than 7% in the last 3 tables, whether it is reported in your beneficiary file or by external laboratory results. - electrocardiogram (ecg) normal or with variations without clinical relevance, with qt interval <450 ms. - no contraindication to study drugs (history of hypersensitivity to study drugs, including macrolides, patients with renal failure (egfr <40 ml / min) or on renal replacement therapy, patients with a history of retinopathy or macular degeneration.